A detailed history of Chapin Davis, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Chapin Davis, Inc. holds 8,548 shares of EW stock, worth $789,578. This represents 0.3% of its overall portfolio holdings.

Number of Shares
8,548
Previous 8,408 1.67%
Holding current value
$789,578
Previous $641 Million 27.41%
% of portfolio
0.3%
Previous 0.27%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$72.54 - $95.56 $10,155 - $13,378
140 Added 1.67%
8,548 $817 Million
Q4 2023

Jan 11, 2024

BUY
$61.71 - $77.76 $6,171 - $7,776
100 Added 1.2%
8,408 $641 Million
Q3 2023

Oct 19, 2023

BUY
$69.28 - $93.38 $19,744 - $26,613
285 Added 3.55%
8,308 $576 Million
Q2 2023

Aug 30, 2023

SELL
$81.41 - $94.33 $9,932 - $11,508
-122 Reduced 1.5%
8,023 $757 Million
Q1 2023

Apr 12, 2023

BUY
$74.26 - $84.51 $21,906 - $24,930
295 Added 3.76%
8,145 $674 Million
Q4 2022

Jan 27, 2023

BUY
$68.3 - $87.44 $536,155 - $686,404
7,850 New
7,850 $586 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $57.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Chapin Davis, Inc. Portfolio

Follow Chapin Davis, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chapin Davis, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chapin Davis, Inc. with notifications on news.